Talphera reduces board from 10 to 7; three directors resign; regains Nasdaq bid price compliance

TALPHERA, INC.

Directors Richard Afable, Howard Rosen, and Pamela Palmer resigned effective Feb 26-28, 2024, no disagreements.
Board size reduced from ten to seven directors; committees reconstituted with continuing members.
Nasdaq notified Talphera on Feb 27 that it regained compliance with $1.00 minimum bid price rule as of Feb 26, 2024.
Pamela Palmer remains Chief Medical Officer; focus on Niyad registrational study.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Howard B. Rosen

Director

TLPH · TALPHERA, INC.

Effective: 2024-02-26
Filed: March 1, 2024, 6:59 PM ET

On February 26, 2024, Richard Afable, M.D. and Howard B. Rosen resigned as members of the board of directors of Talphera, Inc. (the "Company"), and any and all committees thereof, effective immediately.

Departed

Richard Afable, M.D.

Director

TLPH · TALPHERA, INC.

Effective: 2024-02-26
Filed: March 1, 2024, 6:59 PM ET

On February 26, 2024, Richard Afable, M.D. and Howard B. Rosen resigned as members of the board of directors of Talphera, Inc. (the "Company"), and any and all committees thereof, effective immediately.

Departed

Pamela P. Palmer, M.D., Ph.D.

Director

TLPH · TALPHERA, INC.

Effective: 2024-02-28
Filed: March 1, 2024, 6:59 PM ET

On February 28, 2024, Pamela P. Palmer, M.D., Ph.D. resigned as a member of the Company's board of directors effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Howard B. Rosen resigned as Director at TALPHERA, INC..

Action: resigned
Role: Director

Exact text from the filing

On February 26, 2024, Richard Afable, M.D. and Howard B. Rosen resigned as members of the board of directors of Talphera, Inc. (the "Company"), and any and all committees thereof, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Afable, M.D. resigned as Director at TALPHERA, INC..

Action: resigned
Role: Director

Exact text from the filing

On February 26, 2024, Richard Afable, M.D. and Howard B. Rosen resigned as members of the board of directors of Talphera, Inc. (the "Company"), and any and all committees thereof, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Pamela P. Palmer, M.D., Ph.D. resigned as Director at TALPHERA, INC..

Action: resigned
Role: Director

Exact text from the filing

On February 28, 2024, Pamela P. Palmer, M.D., Ph.D. resigned as a member of the Company's board of directors effective immediately.

View on SEC.gov

TALPHERA, INC. filing history →

Source: SEC EDGAR

accession 0001437749-24-006219

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.